Transcript Slide 1

Acute Coronary
Syndrome
APS
Fleming College
What is an ACS?
A sudden event during which the myocardium
suffers from a relative or a complete lack of
perfusion
Covers the continuum between angina and MI
This is reflected in:
 Signs
and symptoms
 Electrocardiographic changes
 Biochemical changes
Symptoms of ACS
Pain
– Pressure
– Burning (hot)
– Chest/arms/jaw/back
Sympathetic response
– Sweats
– Tachycardia
– Cool, clammy skin
Parasympathetic response
– Nausea
– Vomiting
– Weak
Inflammatory response
Other
– Mild fever
– Dyspnea
– Asymptomatic
Physical Findings
 Inspection
BP
- often increase anterior MI
- often decrease inferior MI
HR
- often increase anterior MI
- often decrease inferior MI
RA po
- increase in RV MI
Stable CAD
Acute Coronary Syndromes
Unstable angina
Non-ST Elevation MI
(Non-Q-wave MI)
ST-Elevation MI
(Q-wave MI)
The continuum of acute coronary syndromes ranges from unstable
angina, through non-ST-elevation myocardial infarction (also referred
to as “non-Q-wave” myocardial infarction [MI]), to ST-elevation MI
(also referred to as “Q-wave” MI).
Platelets & ACS
Platelets become
activated by various
stimuli
 Binds to fibrinogen
and serves to crosslink and aggregate
platelets
 Platelet plug
becomes the centre
of a larger thrombus

Triggers to Plaque Rupture
Inflammatory
cytokines
Vulnerable
Plaque
Plaque Rupture
Physical Stress
Emotional
Stress
Extent of Myocardial Injury
Determined by:

muscle mass perfused by vessel

Magnitude/Duration of flow

Oxygen demand of affected tissue

Adequacy of collaterals

Tissue response to ischemia
Preventing ACS / Reducing
Infarct Size
Primary prevention -lifestyle
 Stabilizing plaque
 Preventing platelet aggregation
 Decreasing preload and afterload
 Decreasing cardiac workload
 Reperfusion
 Treating arrhythmia
Which ones do you as medics do??

Pathophysiology of ACS
Myocardial ischemia >>> infarction
1.
Plaque formation with narrowing of coronary artery lumen
2.
Plaque rupture
3.
Thrombus formation with platelet activation and aggregation
4.
Ischemia in downstream territory with reversible cell injury
5.
Myocardial cell death
Cardiovascular Pathology
Angina
 Unstable angina
 Myocardial Infarction
 Congestive heart failure
 Valvular dysfunction
 Cardiogenic shock
 Aneurysms
 Deep vein thrombosis/arterial occlusion

Ischemic Chest Pain

Good history and physical exam

3 & 12/15lead ECG

OPQRST to guide history investigation

Differential diagnosis
Chapter 27
27.24-27.36
OPQRST
Onset - when did it start?
 Provoked - at rest, exertion, better or
worse?
 Quality - sharp, dull, ache, heaviness?
 Radiating - to shoulder, back, jaw?
 Severity - on a scale of 1-10?
 Time - does it come and go?

Myocardial Ischemia
 Blood
supply and
demand
 Causes of ischemia
– too slow or too fast
 vasospasm (Prinzmetals)
 coronary artery occlusion
 narrowing of coronary
arteries
 low blood pressure
 hypoxemia
 HR
Coronary Artery Disease

Poor dietary habits

Imbalance between good cholesterol
(HDL)
and bad cholesterol (LDL)

Atherosclerosis
That’s why there are
angiograms!
Angina or MI??
myocardial ischemia
Decreased perfusion
angina
Supply and demand
unstable angina
myocardial infarction
CP pattern changes or
complicated
Total occlusion and
necrosis
Consequences of
Coronary Thrombosis
Lilly. Pathophysiology of Heart Disease, 4th Ed. Lippincott Williams, 2007. Page 173
The Importance of History
Someone with angina knows their typical
pattern
 In addition to OPQRST, take an AMPLE
history
 “are you SOB?”
 Similar pain?
 MI in past? Is this pain similar?
 Other cardiac Hx? e.g. CABG, angioplasty
,stress testing, hospitalizations etc.

Angina
Lasts less than 30 minutes
 Heaviness, dull, tight or even sharp
pain
 Can radiate but less common
 Usually on exertion and dissipates
with rest
 Temporary drop in coronary artery
blood flow
 Rule out rate related problems

Angina Management
Rest/relaxation (Be calm!)
 O2 therapy
 IV access ?
 ASA 160mg chewed & swallowed
 Vitals
 Nitroglycerin 0.4mg SL q 5 min. if SBP
>100 and
HR > 60 but less than 160 bpm

 HR
and blood pressure parameters…why?
Hemodynamic Parameters

SBP < 100
 preload
reduction - vasodilation
 decreased coronary perfusion

HR < 60 bpm or > 160 bpm
 rate
related ischemia?
Ischemic Chest Pain

Nitroglycerin 0.4mg SL, q 5 min. PRN
 Assess
VS after each dose
 d/c if SBP <100 or SBP drops by 1/3
 d/c if HR <60 or >160 bpm
ASA 160mg chewable tablets
 Morphine Sulphate 2mg IV, q 5 min. x 3
PRN

Unstable Angina

Indicates a progression towards serious
myocardial disease

5 Indicators of Unstable Angina
 new
angina pain
 change in the duration
 change in Rx (e.g increased NTG use)
 onset at rest
 change in quality (e.g now radiates)
Acute Myocardial Infarction
Definition:
Necrosis of heart muscle due to absolute
or relative lack of blood supply to the
myocardium.
The site of infarction is determined by the
location of the arterial occlusion.
Myocardial Infarction
Killing of myocardial tissue
 Conventional treatment will only save
ischemic zone
 Thrombolytics

Necrotic zone
Ischemic zone
Presentation of Myocardial
Infarction
Varies widely from patient to patient
 Typical vs. Atypical (e.g.. weakness or
SOB)
 The elderly, alcoholics, and women
 CP unresolved with rest or NTG
 12 Lead shows acute ST elevation,
Flipped T waves or Q waves (old)

Electrocardiographic Changes

Change in rate and rhythm

Most often sinus with:
 No
discernible change
 Hyper-acute T-waves
 T wave flattening or inversion
 ST segments up or down
 Q waves
Biochemical Markers of ACS
Enzymes which are unique to cardiac
myocytes
 Released into the circulation by dead
cells

 Thus
a rise in these indicates that
myocardium has suffered damage
Biochemical Markers


Troponin (remember its role in actin/myosin
binding??)
CPK (Creatine Phosphokinase)
 Specifically


one isoenzyme -MB band
LDH (Lactose dehydrogenase)
AST
Hospital staff will draw blood for these tests early but
do NOT generally help in the decision making
Cardiac Markers
Myoglobin is found in cardiac and skeletal
muscle
 Very sensitive if measured early


Not specific

Not often used
Use of Nitrates in ACS

Nitrates, typically nitroglycerin

Nitrous Oxide acts as a smooth muscle
relaxant leading to vasodilatation

Transdermally, sublingually and/or
parenterally
Benefits of Nitrates
Reduce
preload and afterload
Dilate coronary arteries
Assists coronary perfusion
Disadvantages of Nitrates
Not
useful in patients who are
reperfused
May cause hypotension
Severe hypotension in patients with RV
dysfunction
May cause hypotension in inferior MI
 30%
have RV involvement-check!!!
b-blockers
Multi-purpose in the setting of ACS
 Anti-arrhythmic
 Anti-ischemic
 Anti-hypertensive
b-blockers
Decrease myocardial oxygen demand
heart rate – increases diastole
 Decreased myocardial contractility
 Decreased MAP
 Decreased
Advantages of b-blockers
Reduction in pain
 Decreased morbidity and mortality
 Decreased risk of arrhythmia
 Decreased infarct size
 Decreased risk of re-infarction

Treatment with a b-blocker is a standard of care
ASA

Anti-inflammatory
 prevents
the formation of arachidonic acid

A pathway that can be blocked to prevent
platelet aggregation

Does not block all platelet activators
Other Treatment Modalities in ACS
Heparins (LMWH)
 Reperfusion

 PCI
 Mechanical
(the digger!)
 Thrombolytic agents

Antiarrhythmic agents
Focus of ACS
Common reason for transport
 Much can be done during transfer
 Reduce risk of morbidity and mortality

The first step = recognizing the ACS
 Signs
and symptoms
 ECG changes
 Biochemical changes
Summary
Strategies for reducing morbidity and mortality
 Reduce
cardiac workload
 Improve perfusion to cardiac tissue
 Reduce risk of fatal arrhythmias
 Reduce extension of clot formation
 Reperfuse the ischemic myocardium
Myocardial Infarction









ASA (2 x 80 mg) P.O.
O2 therapy
IV access
NTG via SL, transdermal, and/or IV
Morphine (ACP)
Heparin and/or Beta blockers (Hosp)
12/15 Lead ECG as soon as possible
Angioplasty (hosp)
Thrombolytics if PCI not available or
contraindicated
PCI
Pre-hospital Thrombolysis
Oshawa Land ALS
 Northern Ornge Bases

 Frequent

Southern Ornge Bases
 Carry

use
it
Positive empirical trends
Pre-hospital Thrombolysis

prolonged transport time

no thrombolysis at the sending facility

Long delays
Indications - Thrombolysis
 Ischemic
 Less
C.P.
than 6 hours duration
Ischemic Chest Pain?
O - at rest or with exertion
P – better or worse
Q - heaviness, tightening, sharp, weakness
etc
R - neck, jaw and/or left arm
S - varies
T - consistent, does NOT come & go
12 Lead ECG Criteria
ST segment elevation
 New onset Left Bundle Branch Block
with S&S?
 Some acute coronary syndromes
(A.C.S.) do not benefit from
thrombolysis

Next
We will be looking at 12 leads specifically
 Look at the hand powerpoint (12lead)
 Read the sample handouts
 Read your text 12 lead ECG (big book)
